Maternal obesity induces developmental programming of Intestinal stem cells through an IL-17A/PPAR immune-epithelial axis

Maternal obesity programs intestinal stem cells in offspring to exhibit enhanced proliferation, self-renewal, and tumor susceptibility through a persistent immune-epithelial axis driven by IL-17A and PPAR signaling.

The Gist

The Big Picture: A "Bad Start" That Lasts a Lifetime

Imagine your body is a massive, bustling city. The Intestinal Stem Cells (ISCs) are the city's construction crews. They are the workers who constantly repair the roads (the gut lining) and build new buildings. Usually, these crews are very disciplined; they build exactly what is needed and stop when the job is done.

This paper asks a scary question: What happens if the construction crew is trained by a mother who is living in a chaotic, unhealthy environment?

The researchers found that if a mother is obese (specifically, eating a high-fat "Western" diet) while she is pregnant and breastfeeding, she accidentally "programs" her baby's construction crews to be hyper-active, greedy, and prone to building dangerous structures later in life. Even if the baby grows up eating a perfectly healthy diet, that "bad training" never goes away.

The Story in Three Acts

Act 1: The Mother's Diet Sets the Stage

The researchers used mice to simulate this. They fed pregnant and nursing mothers a diet high in fat and sugar (like a constant diet of burgers, fries, and soda).

• The Result: The baby mice were born with "super-charged" stem cells. These cells multiplied faster, worked harder, and were more likely to turn into a specific type of cell (secretory cells) that the researchers didn't expect.
• The Analogy: Think of it like a coach who is stressed and angry. Instead of teaching the players to play a balanced game, the coach screams, "Go! Go! Go!" The players learn to run at full speed forever. Even if the coach stops screaming later, the players can't remember how to slow down.

Act 2: The Culprit is a "Fire Alarm" (IL-17A)

Why did the stem cells go crazy? The researchers found the culprit: a chemical signal called IL-17A.

• The Mechanism: The mother's obesity caused her immune system to send out IL-17A. This is a cytokine, which is basically a chemical "fire alarm" used by the immune system to fight infection.
• The Twist: In this case, the fire alarm wasn't fighting a real fire. It was just ringing constantly because of the bad diet. The baby's gut stem cells heard this alarm and thought, "Oh no, we need to build defenses fast!" So, they started multiplying wildly.
• The Analogy: Imagine a neighborhood where the fire alarm is stuck in the "ON" position. The fire department (the stem cells) keeps rushing to the scene, building fire stations and hoses everywhere, even though there is no fire. They get so used to this frantic pace that they forget how to relax.

Act 3: The "Switch" That Can't Be Turned Off

Here is the most shocking part. The researchers tried to fix the problem by:

1. Feeding the baby mice a healthy diet after they were born.
2. Giving the mice medicine to block the IL-17A "fire alarm" after they were born.

It didn't work. The stem cells were still hyper-active.

• The Discovery: The damage was done during the pregnancy and early infancy. The stem cells had been "re-wired" permanently.
• The Key Players: The researchers found that the stem cells use a specific internal switch called PPAR to listen to the IL-17A alarm. Once the switch was flipped during early development, the stem cells became "metabolically hyperactive" (they burned energy like crazy) and "immune-blind" (they stopped listening to safety signals).
• The Analogy: It's like programming a computer's BIOS (the deep system settings) while it's being built in the factory. If you set the computer to "Turbo Mode" while it's being assembled, you can't fix it later by just changing the software or the keyboard. You have to re-wire the motherboard.

The Consequence: A City Prone to Disasters

Because these stem cells are so eager to grow and divide, they are much more likely to make mistakes.

• The researchers tested this by removing a "brake" gene (called Apc) that usually stops tumors from forming.
• The Result: The mice exposed to the maternal obesity developed much larger and more numerous tumors than the control group.
• The Takeaway: The "bad training" made the stem cells so fit and aggressive that when a cancer trigger appeared, they seized the opportunity to grow tumors much faster.

Why This Matters for Humans

This study helps explain a real-world mystery: Why is early-onset colorectal cancer (cancer in young people) rising so fast?

It suggests that the seeds of this disease might be planted before we are even born. If a mother is obese during pregnancy, she might be inadvertently training her child's gut cells to be "cancer-prone" for the rest of their life.

Summary in One Sentence

A mother's obesity during pregnancy acts like a permanent "Turbo Button" on her baby's gut stem cells, training them to grow too fast and ignore safety signals, which makes them much more likely to turn into cancer later in life, even if the baby eats healthy food.

Technical Summary

1. Problem Statement

Maternal obesity is epidemiologically linked to an increased risk of sporadic colorectal cancer (CRC) in offspring, suggesting that early-life environmental exposures durably shape disease susceptibility. While adult studies have shown that high-fat diets (HFD) can reprogram intestinal stem cells (ISCs) via metabolic pathways, the mechanisms by which maternal obesity programs ISCs during critical developmental windows (fetal and early postnatal) remain poorly understood. Specifically, it is unknown how maternal metabolic states translate into long-lasting, stable changes in offspring ISC function, lineage commitment, and tumor susceptibility, even after the offspring return to a normal diet.

2. Methodology

The study employed a multi-disciplinary approach combining in vivo mouse models, ex vivo organoid cultures, and human stem cell differentiation to dissect the mechanism of developmental programming.

• Animal Models:

  • Maternal Diet-Induced Obesity (mHFD): Female C57BL/6J mice were fed a 60% kcal high-fat Western diet (HFD) starting 3 days prior to mating and maintained throughout gestation and lactation. Offspring were weaned at day 21 (d21) onto a control diet (CON) to isolate the effects of maternal exposure from post-weaning diet.
  • Genetic Knockouts: The study utilized intestinal epithelial-specific knockouts:
    • Il17ra^fl/fl; VilCre (Epithelial IL-17 receptor A deficient).
    • Ppard^fl/fl; Ppara^fl/fl; VilCre (Dual PPAR$\delta$/$\alpha$ deficient).
    • Cpt1a^fl/fl; VilCre (CPT1A deficient).
    • Apc^fl/+; VilCre (Tumor susceptibility model).
  • Intervention: Post-weaning antibody neutralization of IL-17A was performed to test if continuous signaling was required to maintain the phenotype.

• In Vitro Models:

  • Mouse Organoids: Derived from embryonic (e18.5), d21, and d50 crypts. Treated with recombinant cytokines (IL-17A, IL-22, IL-13, etc.) to test sufficiency.
  • Human Colon Organoids (hCOs): Differentiated from human embryonic stem cells (hESCs) to mimic the hindgut differentiation window. Treated with human IL-17A to assess cross-species conservation.

• Analytical Techniques:

  • Single-Cell RNA Sequencing (scRNA-seq): Performed on distal colonic crypts (EpCAM+ epithelial and CD45+ immune cells) at d21 and d50 to map lineage shifts and transcriptional programs.
  • Bulk RNA-seq: Used for pathway analysis of crypts from various genotypes.
  • Functional Assays: Organoid formation efficiency (clonogenicity), BrdU incorporation (proliferation), and lineage tracing (Lgr5-CreERT2; Rosa26TdTomato).
  • Molecular Profiling: smFISH (for Lgr5, Atoh1, MUC2), qRT-PCR, ELISA (cytokine levels), and flow cytometry (immune cell subsets).

3. Key Contributions

The paper establishes a novel mechanistic link between maternal metabolic health and offspring cancer risk by identifying a specific immune-epithelial signaling axis that programs stem cells during development.

1. Discovery of Developmental Programming: Demonstrated that maternal HFD exposure induces a stable, self-renewing program in offspring ISCs that persists into adulthood (d100) despite dietary normalization, distinct from the reversible effects of adult-onset HFD.
2. Identification of the IL-17A/PPAR Axis: Uncovered a specific cytokine-nuclear receptor axis where maternal obesity drives local IL-17A production, which signals through epithelial IL-17RA to activate PPAR$\delta$/$\alpha$, thereby altering stem cell metabolism and fate.
3. Lineage Reprogramming: Revealed that this programming shifts the ISC lineage bias toward secretory cell fates (goblet and enteroendocrine cells) via the transcription factor Atoh1, rather than absorptive fates.
4. Human Relevance: Validated that IL-17A treatment of human colon organoids recapitulates the proliferative and lineage-shift phenotypes observed in mice, suggesting a conserved mechanism in humans.

4. Key Results

• Persistent ISC Expansion and Hypermetabolism:

  • Offspring of mHFD dams exhibited increased Lgr5+ ISC numbers, enhanced proliferation (BrdU+), and superior organoid-forming capacity at d21, d50, and d100.
  • scRNA-seq revealed a hypermetabolic state in mHFD-programmed ISCs, characterized by upregulation of oxidative phosphorylation, fatty acid metabolism, and glutathione metabolism.
  • Conversely, these cells showed a hypoimmune state, with downregulation of antigen presentation and barrier maintenance pathways.

• Lineage Bias:

  • mHFD exposure caused a durable expansion of secretory lineages (Goblet cells, MUC2+; Enteroendocrine cells, PYY+; and Atoh1+ progenitors).
  • This bias persisted even after weaning, indicating a "fixed" developmental state.

• The Role of IL-17A:

  • Source: mHFD led to a chronic, tissue-localized expansion of IL-17A-producing immune cells (specifically $\gamma\delta$ T cells and Th17 cells) in the offspring colon.
  • Sufficiency: Treating naive organoids (from e18.5 embryos) with IL-17A recapitulated the mHFD phenotype: increased proliferation, ISC expansion, and secretory bias. Other cytokines (IL-22, IL-13, TNF-$\alpha$) failed to do so.
  • Necessity (Timing):
    • Post-weaning blockade: Neutralizing IL-17A after weaning did not reverse the established phenotype, proving the programming is fixed during the developmental window.
    • Developmental ablation: Epithelial-specific knockout of Il17ra (Il17ra^iKO) completely abolished the mHFD-induced ISC expansion, proliferation, and secretory bias.

• The Role of PPAR$\delta$/$\alpha$:

  • IL-17A signaling induced the expression of Ppard and Cpt1a.
  • Epithelial knockout of Ppard and Ppara (Ppard/a^iKO) blocked the mHFD phenotype, preventing ISC expansion and lineage shifts.
  • In Ppard/a^iKO organoids, IL-17A treatment failed to induce the hypermetabolic gene signature or the secretory bias, confirming PPARs are the intrinsic mediators of the IL-17A signal.

• Tumor Susceptibility:

  • In an Apc^fl/+ model, mHFD-exposed offspring developed significantly larger $\beta$-catenin+ adenomatous lesions in the distal colon compared to controls, demonstrating that this programming increases oncogenic susceptibility.

5. Significance

This study fundamentally shifts the understanding of how early-life environmental exposures contribute to adult disease.

• Mechanistic Insight: It moves beyond correlation to define a specific molecular pathway (Maternal HFD $\rightarrow$ Immune IL-17A $\rightarrow$ Epithelial IL-17RA $\rightarrow$ PPAR$\delta$/$\alpha$ $\rightarrow$ ISC Reprogramming).
• DOHaD Framework: It provides a concrete example of the "Developmental Origins of Health and Disease" (DOHaD) paradigm, showing how non-pathogenic inflammation (driven by maternal diet) can permanently alter tissue stem cell fitness.
• Clinical Implications: The findings suggest that the rising incidence of early-onset colorectal cancer may be rooted in prenatal metabolic environments. Furthermore, it highlights that interventions targeting the IL-17A/PPAR axis during critical developmental windows (rather than just in adulthood) might be necessary to prevent the establishment of pro-tumorigenic stem cell states.
• Therapeutic Target: The identification of IL-17A as a key driver suggests that modulating this specific immune-epithelial crosstalk could be a strategy to mitigate the long-term cancer risks associated with maternal obesity.